Cargando…

Development of a Generic PBK Model for Human Biomonitoring with an Application to Deoxynivalenol

Toxicokinetic modelling provides a powerful tool in relating internal human exposure (i.e., assessed through urinary biomarker levels) to external exposure. Chemical specific toxicokinetic models are available; however, this specificity prevents their application to similar contaminants or to other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Notenboom, Sylvia, Hoogenveen, Rudolf T., Zeilmaker, Marco J., Van den Brand, Annick D., Assunção, Ricardo, Mengelers, Marcel J. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535232/ https://www.ncbi.nlm.nih.gov/pubmed/37755995 http://dx.doi.org/10.3390/toxins15090569

Ejemplares similares

Biomonitoring of Deoxynivalenol and Deoxynivalenol-3-glucoside in Human Volunteers: Renal Excretion Profiles
por: Mengelers, Marcel, et al.
Publicado: (2019)

Modelling the Renal Excretion of the Mycotoxin Deoxynivalenol in Humans in an Everyday Situation
por: van den Brand, Annick D., et al.
Publicado: (2021)

Physiologically based kinetic (PBK) modelling and human biomonitoring data for mixture risk assessment
por: Pletz, Julia, et al.
Publicado: (2020)

Biomonitoring Study of Deoxynivalenol Exposure in Chinese Inhabitants
por: Wang, Xiaodan, et al.
Publicado: (2019)

Current Advances, Research Needs and Gaps in Mycotoxins Biomonitoring under the HBM4EU—Lessons Learned and Future Trends
por: Alvito, Paula, et al.
Publicado: (2022)

Human Mycotoxin Biomonitoring: Conclusive Remarks on Direct or Indirect Assessment of Urinary Deoxynivalenol
por: Vidal, Arnau, et al.
Publicado: (2020)

Internal Relative Potency Factors for the Risk Assessment of Mixtures of Per- and Polyfluoroalkyl Substances (PFAS) in Human Biomonitoring
por: Bil, Wieneke, et al.
Publicado: (2022)

Development, testing, parameterisation, and calibration of a human PBK model for the plasticiser, di (2-ethylhexyl) adipate (DEHA) using in silico, in vitro and human biomonitoring data
por: McNally, Kevin, et al.
Publicado: (2023)

Human biomonitoring of deoxynivalenol (DON) - Assessment of the exposure of young German adults from 1996 - 2021
por: Schmied, Andy, et al.
Publicado: (2023)

Humans significantly metabolize and excrete the mycotoxin deoxynivalenol and its modified form deoxynivalenol-3-glucoside within 24 hours
por: Vidal, Arnau, et al.
Publicado: (2018)

Providing Biological Plausibility for Exposure–Health Relationships for the Mycotoxins Deoxynivalenol (DON) and Fumonisin B1 (FB1) in Humans Using the AOP Framework
por: van den Brand, Annick D., et al.
Publicado: (2022)

PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas
por: Zhu, Kejing, et al.
Publicado: (2022)

Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment
por: Najjar, Abdulkarim, et al.
Publicado: (2022)

PBK/TOPK Expression Predicts Prognosis in Oral Cancer
por: Chang, Chin-Fang, et al.
Publicado: (2016)

PBK/TOPK: A Therapeutic Target Worthy of Attention
por: Han, Ziping, et al.
Publicado: (2021)

An Integrative Pan-Cancer Analysis of PBK in Human Tumors
por: Wen, Huantao, et al.
Publicado: (2021)

ADME characterization and PBK model development of 3 highly protein-bound UV filters through topical application
por: Li, Hequn, et al.
Publicado: (2023)

Biomonitoring of Aflatoxin B(1) and Deoxynivalenol in a Rural Pakistan Population Using Ultra-Sensitive LC-MS/MS Method
por: Xia, Lei, et al.
Publicado: (2020)

Metabolism of Deoxynivalenol and Deepoxy-Deoxynivalenol in Broiler Chickens, Pullets, Roosters and Turkeys
por: Schwartz-Zimmermann, Heidi E., et al.
Publicado: (2015)

PBK/TOPK: An Effective Drug Target with Diverse Therapeutic Potential
por: Huang, Hai, et al.
Publicado: (2021)

PBK correlates with prognosis, immune escape and drug response in LUAD
por: Ma, Hongyu, et al.
Publicado: (2023)

Risk assessment of deoxynivalenol in high-risk area of China by human biomonitoring using an improved high throughput UPLC-MS/MS method
por: Deng, Chunli, et al.
Publicado: (2018)

PBK/TOPK mediates geranylgeranylation signaling for breast cancer cell proliferation
por: Dou, Xiaoyan, et al.
Publicado: (2015)

Identification of PBK as a hub gene and potential therapeutic target for medulloblastoma
por: Deng, Yuhao, et al.
Publicado: (2022)

Protein Adductomics: Analytical Developments and Applications in Human Biomonitoring
por: Preston, George W., et al.
Publicado: (2019)

Next generation physiologically based kinetic (NG-PBK) models in support of regulatory decision making
por: Paini, A., et al.
Publicado: (2019)

Biomonitoring in the Era of the Exposome
por: Dennis, Kristine K., et al.
Publicado: (2016)

Biodegradation of Deoxynivalenol by Nocardioides sp. ZHH-013: 3-keto-Deoxynivalenol and 3-epi-Deoxynivalenol as Intermediate Products
por: Zhang, Honghai, et al.
Publicado: (2021)

PSMB8 and PBK as potential gastric cancer subtype-specific biomarkers associated with prognosis
por: Kwon, Chae Hwa, et al.
Publicado: (2016)

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
por: Ohashi, Takuma, et al.
Publicado: (2017)

PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis
por: Xu, Ming, et al.
Publicado: (2019)

A novel loss-of-function mutation of PBK associated with human kidney stone disease
por: Nettuwakul, Choochai, et al.
Publicado: (2020)

PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma
por: Wang, Meng-Yao, et al.
Publicado: (2021)

Expression patterns and clinical significances of PBK in lung cancer: an analysis based on Oncomine database
por: Li, Jinglei, et al.
Publicado: (2021)

Down-regulation of PBK inhibits proliferation of human endometrial stromal cells in thin endometrium
por: Zhu, Qi, et al.
Publicado: (2022)

PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers
por: Lee, Dong-Hee, et al.
Publicado: (2022)

Combined Exposure to Multiple Mycotoxins: An Example of Using a Tiered Approach in a Mixture Risk Assessment
por: van den Brand, Annick D., et al.
Publicado: (2022)

Hydrolytic fate of deoxynivalenol-3-glucoside during digestion
por: Berthiller, Franz, et al.
Publicado: (2011)

Applicability of non-invasively collected matrices for human biomonitoring
por: Smolders, Roel, et al.
Publicado: (2009)

Clinical impact of deoxynivalenol, 3-acetyl-deoxynivalenol and 15-acetyl-deoxynivalenol on the severity of an experimental Mycoplasma hyopneumoniae infection in pigs
por: Michiels, Annelies, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cep8asggdjbia0t06vfqii8nav